Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningHematopoietic Stem Cell MobilizationMelphalanCombined Modality TherapyMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseHematologic NeoplasmsLeukapheresisTreatment OutcomeGranulocyte Colony-Stimulating FactorStem CellsCyclophosphamideBone Marrow TransplantationAntigens, CD34Myeloablative AgonistsRemission InductionGraft SurvivalRecurrenceBlood Component RemovalEtoposideHematopoietic Stem CellsBusulfanLymphoma, Non-HodgkinDisease-Free SurvivalSalvage TherapyThiotepaHodgkin DiseaseCord Blood Stem Cell TransplantationCytarabineTransplantation ChimeraAntineoplastic Agents, AlkylatingCarmustineWhole-Body IrradiationSurvival RateTissue DonorsVincristineSurvival AnalysisAmyloidosisRetrospective StudiesIfosfamideBone Marrow PurgingHistocompatibilityHistocompatibility TestingDoxorubicinTime FactorsImmunosuppressive AgentsLiver TransplantationFollow-Up StudiesLeukemia, Myeloid, AcuteLymphomaPrognosisVidarabineHematopoiesisDexamethasoneLeukemiaTransplantation, IsogeneicPOEMS SyndromeMyelodysplastic SyndromesInfectionMesenchymal Stem Cell TransplantationGraft vs Leukemia EffectPrednisoneAntineoplastic AgentsNeoplasm, ResidualFatal OutcomeFeasibility StudiesLymphoma, Mantle-CellPlatelet CountAntibodies, Monoclonal, Murine-DerivedCell TransplantationNeoplasmsProspective StudiesBlood CellsKidney TransplantationCarboplatinEmbryonic Stem CellsCytomegalovirus InfectionsBone MarrowAnemia, AplasticPrecursor Cell Lymphoblastic Leukemia-LymphomaPodophyllotoxinBoronic AcidsHematologic DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionPyrazinesLymphoma, FollicularHLA AntigensAdult Stem CellsBlood Cell CountLymphoma, T-Cell, PeripheralImmunosuppressionThalidomideTransplantation Immunology